Maggie Aime has over 25 years of experience in healthcare and as a nurse across specialties including oncology, kidney transplant, cardiology, and more. She leverages her rich healthcare experience to ...

A generation ago, a diagnosis of multiple sclerosis often meant a steady decline in quality of life. The autoimmune disease, which affects nearly a million people in the U.S., causes the immune system ...

Multiple sclerosis (MS) is a disease that affects the brain and spinal cord. It can cause fatigue, trouble with balance and coordination, muscle weakness, and vision problems. Having MS doesn’t ...

WEST PALM BEACH, Florida — A comprehensive multiomics analysis of a 6-month phase 2 trial of a ketogenic diet in multiple sclerosis (MS) confirmed significant anti-inflammatory effects, aligning with ...

– Enrollment Completed for Both Phase 3 ENSURE Trials of Vidofludimus Calcium in Relapsing Multiple Sclerosis; Top-Line Data Expected End of 2026 – – Additional Data from Phase 2 CALLIPER Trial in ...

Women are less likely than men to receive drugs for multiple sclerosis (MS) between the ages of 18 to 40, during women's childbearing years, even when those drugs have been shown to be safe for use ...

Lipoic acid (LA), an oral antioxidant supplement, was not associated with greater improvements in timed walking speed or other clinical outcomes in patients with progressive multiple sclerosis (MS) ...

– Vidofludimus Calcium Demonstrated Statistically Significant 24-Week Confirmed Disability Improvement in Phase 2 CALLIPER Trial in Progressive Multiple Sclerosis, With Over Two-Fold Probability Over ...

Secondary progressive multiple sclerosis (SPMS) usually develops after years of relapsing-remitting multiple sclerosis (RRMS) and leads to steadily worsening symptoms and disability over time. SPMS ...